Newsroom
MedPro Systems Launches State Drug Price Reporting Reference Solution
MOUNT ARLINGTON, N.J., Jan. 31, 2023 — MedPro Systems, the leading provider of commercial and compliance solutions for the Life Sciences industry, today launched an expansion to their authoritative transparency reference library solution, RegulatoryID, to cover US state drug price reporting regulations. With this expansion, pharmaceutical manufacturers can view and…
Webinar: Navigate State Drug Price Reporting with Ease
From launching a new product to adjusting existing price structures, it’s critical that pharmaceutical manufacturers are aware of how their pricing decisions can trigger state-level reporting obligations across the US. However, with more than 30 unique reporting requirements already enacted and more pending legislation on the way, it can be…
MedPro Systems Strengthens SAP Concur Partnership with New SAP Concur Endorsed Apps to Support Life Sciences Customers
Delivering Integrated Search, Capture and Export of Accurate Healthcare License Data in Concur Expense and Concur Invoice to Comply with US and International Transparency Reporting Regulations Mount Arlington, N.J., November 03, 2022 — MedPro Systems, a leading provider of healthcare data, aggregate spend and compliance solutions to the Life Sciences…
Top 10 Common Transparency Mistakes Made by Life Sciences Companies…
Whether you are looking for guidance on the rules, benchmarking & best practices, or simply need help getting it all done, MedPro is your trusted partner…
MedPro Systems Webinar: Top 10 Transparency Mistakes Life Sciences Companies Should Avoid
With more than 30 years of experience and 700+ Life Sciences customers today, we’ve seen it all and we’re here to help! In this webinar, MedPro Systems regulatory experts cover the top 10 common transparency mistakes we’ve seen Life Sciences companies make and how to avoid them. Dive deep with…
Italy Implements New Transparency Reporting Regulations
Italian Sunshine Act Overview In May 2022, Italy approved a new national transparency law regulating relations between pharmaceutical & medical device manufacturers and people operating in the healthcare sector, including healthcare organizations. Unofficially dubbed the ‘Italian Sunshine Act,’ the law takes inspiration from US Federal Open Payments reporting (colloquially referred…